Are further studies planned with the Jewish population in the Washington D.C. area?
Yes. The NIH researchers are developing a follow-up study in the greater Washington, D.C. Jewish community with an option to be tested and receive individual test results for the three alterations in BRCA1 and BRCA2. All participants will receive counseling as to the risks and benefits of genetic testing. This study will also try to identify risk factors that might interact with BRCA1 and BRCA2 and modify someone’s chance of getting breast, ovarian, and prostate cancer. Risk factors under consideration are hormonal factors and additional gene alterations.
